Related references
Note: Only part of the references are listed.FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2010)
Serum fucose level in malignant diseases
N. G. Sawke et al.
INDIAN JOURNAL OF CANCER (2010)
Structure of a fucose transporter in an outward-open conformation
Shangyu Dang et al.
NATURE (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Changes in Tumor Vascularity Depicted by Contrast-Enhanced Ultrasonography as a Predictor of Chemotherapeutic Effect in Patients With Unresectable Pancreatic Cancer
Katsunobu Tawada et al.
PANCREAS (2009)
Treatment of hepatocellular carcinoma by AdAFPep/Rep, AdAFPep/p53, and 5-fluorouracil in mice
Tamotsu Sagawa et al.
HEPATOLOGY (2008)
A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable advanced pancreatic cancer after vascular supply distribution via superselective embolization
Koji Miyanishi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: A glycopeptide approach
Michiko Tajiri et al.
GLYCOBIOLOGY (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Accumulation of liposome with Sialyl Lewis X to inflammation and tumor region:: Application to in vivo bio-imaging
Masahiko Hirai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Donald M. Arnold et al.
ANNALS OF INTERNAL MEDICINE (2007)
Activation of the human complement system by cholesterol-rich and pegylated liposomes - Modulation of cholesterol-rich liposome-mediated complement activation by elevated serum LDL and HDL levels
S. Moein Moghimi et al.
JOURNAL OF LIPOSOME RESEARCH (2006)
Arming antibodies for cancer therapy
P Polakis
CURRENT OPINION IN PHARMACOLOGY (2005)
Arming antibodies: prospects and challenges for immunoconjugates
AM Wu et al.
NATURE BIOTECHNOLOGY (2005)
Loss of disialyl Lewisa, the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (siglec-7) associated with increased sialyl lewisa expression on human colon cancers
K Miyazaki et al.
CANCER RESEARCH (2004)
Fucose: biosynthesis and biological function in mammals
DJ Becker et al.
GLYCOBIOLOGY (2003)
Synthesis of disialyl Lewis a (Lea) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of α-series gangliosides
A Tsuchida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Chemotherapy for pancreatic cancer
S Shore et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Mannose receptor-mediated regulation of serum glycoprotein homeostasis
SJ Lee et al.
SCIENCE (2002)
Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice
S Kawakami et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2000)
New approaches to antibody therapy
LM Weiner et al.
ONCOGENE (2000)
Share Paper
